Literature DB >> 17684256

Lentzea kentuckyensis sp. nov., of equine origin.

D P Labeda1, J M Donahue2, S F Sells2, R M Kroppenstedt3.   

Abstract

A novel actinomycete, designated strain LDDC 2876-05(T), was isolated from an equine placenta during the course of routine diagnostic tests for nocardioform placentitis. In a preliminary study, the strain was observed to be phylogenetically distinct from the genera Crossiella and Amycolatopsis and probably a member of the genus Lentzea. A polyphasic study of strain LDDC 2876-05(T) confirmed its identification as a member of Lentzea on the basis of its chemotaxonomic and morphological similarity to all of the known species of the genus. Moreover, the strain could be distinguished from other species with validly published names on the basis of its phylogenetic and physiological characteristics and its fatty acid profile. Therefore strain LDDC 2876-05(T) represents a novel species of the genus Lentzea, for which the name Lentzea kentuckyensis sp. nov. is proposed. The type strain is LDDC 2876-05(T) (=NRRL B-24416(T) =DSM 44909(T)).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684256     DOI: 10.1099/ijs.0.64245-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  2 in total

1.  Genome-Based Taxonomic Classification of the Phylum Actinobacteria.

Authors:  Imen Nouioui; Lorena Carro; Marina García-López; Jan P Meier-Kolthoff; Tanja Woyke; Nikos C Kyrpides; Rüdiger Pukall; Hans-Peter Klenk; Michael Goodfellow; Markus Göker
Journal:  Front Microbiol       Date:  2018-08-22       Impact factor: 5.640

2.  Proposal of Lentzea deserti (Okoro et al. 2010) Nouioui et al. 2018 as a later heterotypic synonym of Lentzea atacamensis (Okoro et al. 2010) Nouioui et al. 2018 and an emended description of Lentzea atacamensis.

Authors:  Mo Ping; Zhao Yun-Lin; Liu Jun; Gao Jian; Xu Zheng-Gang
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.